Pennsylvania 2025 2025-2026 Regular Session

Pennsylvania House Bill HB446 Introduced / Bill

                     
PRINTER'S NO. 424 
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL 
No.446 
Session of 
2025 
INTRODUCED BY SANCHEZ, KHAN, GUENST, GIRAL, PIELLI, HOWARD, 
DONAHUE, HADDOCK, HILL-EVANS, FREEMAN, FLEMING, CIRESI, 
CERRATO AND GREEN, FEBRUARY 3, 2025 
REFERRED TO COMMITTEE ON HEALTH, FEBRUARY 3, 2025 
AN ACT
Amending the act of July 19, 1979 (P.L.130, No.48), entitled "An 
act relating to health care; prescribing the powers and 
duties of the Department of Health; establishing and 
providing the powers and duties of the State Health 
Coordinating Council, health systems agencies and Health Care 
Policy Board in the Department of Health, and State Health 
Facility Hearing Board in the Department of Justice; 
providing for certification of need of health care providers 
and prescribing penalties," in licensing of health care 
facilities, providing for medication offered to patient.
The General Assembly of the Commonwealth of Pennsylvania 
hereby enacts as follows:
Section 1.  The act of July 19, 1979 (P.L.130, No.48), known 
as the Health Care Facilities Act, is amended by adding a 
section to read:
Section 809.3.  Medication offered to patient.
(a)  General rule.--For a facility-provided medication 
administered to a patient during an episode of care in a health 
care facility, any portion of the medication billed to the 
patient that is unused shall be offered to the patient at no 
additional charge upon discharge when the medication may be 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21 required for continuing treatment.
(b)  Facility option.--For a facility-provided medication 
administered to a patient during an episode of care in a health 
care facility, any portion of the medication that is unused that 
would otherwise be wasted shall be offered to the patient at no 
additional charge upon discharge when the medication is required 
for continuing treatment.
(c)  Labeling.--A facility-provided medication shall be 
labeled consistent with labeling requirements under the act of 
September 27, 1961 (P.L.1700, No.699), known as the "Pharmacy 
Act."
(d)  Counseling waived.--If a facility-provided medication is 
used in an operating room or emergency department setting, the 
prescriber shall counsel the patient on the medication's proper 
use and administration and the requirements of pharmacist 
counseling shall be waived.
(e)  Definitions.--As used in this section, the following 
words and phrases shall have the meanings given to them in this 
subsection unless the context clearly indicates otherwise:
"Facility-provided medication."  A topical antibiotic, anti-
inflammatory, dilation or glaucoma drop or ointment or nasal 
spray that a health care facility employee has on standby or 
that is retrieved from a dispensing system for a specified 
patient for use during a procedure or visit.
"Prescriber."  A person that is licensed, registered or 
otherwise authorized to distribute, dispense or administer a 
controlled substance, other drug or device in the course of 
professional practice or research in this Commonwealth. The term 
does not include a veterinarian.
Section 2.  This act shall take effect in 60 days.
20250HB0446PN0424 	- 2 - 
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30